It has been demonstrated recently that IL-6 levels were markedly upregulated in HNSCC patients and high IL-6 expression independently predicts tumor recurrence, metastasis, and poor survival (34). This evidence concerns the gene IL6 and head and neck squamous cell carcinoma.